Big Buttons

• CALL TO ACTION: Tell FDA to deny drugmakers’ request

  Drugmakers are urging FDA to prohibit compounded GLP-1s. FDA needs to hear from you and your patients NOW! read more →

• APC to FDA: Just say no to Lilly

  This week APC's lawyers sent a formal comment to the FDA about Eli Lilly’s request that tirzepatide be added to the Demonstrably Difficult to Compound list. read more →

• California BOP sends proposed compounding regs to comment period

  The California State Board of Pharmacy decided to move the modified proposed sterile compounding regulations forward to a 30-day comment period. read more →

• Checking in on the post-Chevron fallout

  What’s happened in the world of federal regulation since the end of Chevron? read more →

• Hi, Noom!

  Welcome to our newest Bronze-level Corporate Patron, Noom! read more →

• PFMs can get 2.5% credit card processing

  A new benefit for APC’s Pharmacy/Facility Members: They may be able to cut their credit card processing fees to just 2.5% – 2.8%. read more →

• Phoenix compounders, rise!

  The latest of APC’s new regional meetings — CompoundED UpDATE — is coming to the Phoenix area December 5. read more →

• APC election results: directors and bylaws

  See the results of APC's elections, including four new directors and several changes to our bylaws. read more →

More News

APC’s fourth annual Owner Summit April 4-6 in LaJolla, Calif., will include a session called “Don’t Bother: Things Not to Try.”  Facilitated by APC’s Savannah Cunningham, the session will be a fast-paced look at ideas, projects, products, and techniques compounding pharmacy owners and teams have tried that … well, they just didn’t work. You don’t have to be present to share a failure with us. Just shoot your “tried and untrue” idea to Savannah@a4pc.org as soon as possible. And sure, we’ll keep your identity anonymous if you like.

By the way: Owner Summit early-bird registration opens Tuesday, January 16!